Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)

NCT01135992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S